Article
A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas.
Scientific reports - 16 Jul 2020
Calabrese Evan, Villanueva-Meyer Javier E, Cha Soonmee
Abstract excerpt
Glioblastoma is the most common malignant brain parenchymal tumor yet remains challenging to treat. The current standard of care-resection and chemoradiation-is limited in part due to the genetic heterogeneity of glioblastoma. Previous studies have identified several tumor genetic biomarkers that are frequently present in glioblastoma and can alter clinical management. Currently, genetic biomarker status is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
